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Physicochemical characterization of two 
deproteinized bovine xenografts
Abstract: Calcium phosphate salts, or more specifically hydroxyapatite, 
are products of great interest in the fields of medical and dental science 
due to their biocompatibility and osteoconduction property. Deprotein-
ized xenografts are primarily constituted of natural apatites, sintered 
or not. Variations in the industrial process may affect physicochemical 
properties and, therefore, the biological outcome. The purpose of this 
work was to characterize the physical and chemical properties of depro-
teinized xenogenic biomaterials, Bio-Oss (Geistlich Biomaterials, Wol-
huser, Switzerland) and Gen-Ox (Baumer S.A., Brazil), widely used as 
bone grafts. Scanning electron microscopy, infrared region spectrosco-
py, X-ray diffraction, thermogravimetry and degradation analysis were 
conducted. The results show that both materials presented porous gran-
ules, composed of crystalline hydroxyapatite without apparent presence 
of other phases. Bio-Oss presented greater dissolution in Tris-HCl than 
Gen-Ox in the degradation test, possibly due to the low crystallinity and 
the presence of organic residues. In conclusion, both commercial materi-
als are hydroxyapatite compounds, Bio-Oss being less crystalline than 
Gen-Ox and, therefore, more prone to degradation.
Descriptors: Dental implantation; Hydroxyapatite; Chemical analysis; 
Physical analysis.
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Introduction
Calcium phosphate salts, in particular hydroxy-
apatite (HA), are materials of great interest for 
treatment of osseous deficiencies due to their bio-
compatibility and osteoconduction property.1 Grafts 
of xenogenic origin have been widely studied due to 
abundant sources and accessible processing costs. 
However, bovine bone processing should be quite 
well controlled in order to avoid disease transmis-
sion,2 and to assure adequate physicochemical prop-
erties for the intended use.3
It is important to mention that the structure of 
apatite is similar among different species.4 Several 
papers in the literature have shown the biocompat-
ibility of deproteinized bovine matrix as bone graft 
material,5-7 which, besides providing a supportive 
structure for osteoconduction, releases calcium and 
phosphate ions essential for osteogenesis.8
The presence of pores in bone graft biomaterials 
has been shown as a requisite of great importance 
for repairing osseous deficiency, favoring the osteo-
conduction through osseous growth also inside the 
pores.9,10 In order to allow the penetration of repair-
ing tissue and osseous neoformation in the pores, 
they should be greater than 100 Pm.11-13
Bio-Oss® (Geistlich Biomaterials, Wolhusen, 
Switzerland) is a widely studied bovine xenograft 
consisting of a mineral osseous matrix obtained af-
ter the removal of the organic components of me-
dullar bovine bone during a thermal treatment at 
300qC.14 Another bovine xenograft available in the 
Brazilian market is Gen-Ox® (Baumer S.A., São 
Paulo, Brazil) obtained through deproteinization at 
high temperatures (between 950 and 1,000qC). The 
increased processing temperature enhances mate-
rial crystallinity4,15 being also concurrent with the 
decomposition of the hydroxyapatite in other phases 
like tricalcium phosphate (TCP). The most crystal-
line biomaterial will be the least degradable, but the 
presence of other phases (usually more soluble than 
HA) may compensate or null this effect.16 The cor-
rect indication of a biomaterial shall depend on its 
physicochemical properties. Thus, the aim of this 
study was the physicochemical characterization of 
the products Bio-Oss and Gen-Ox, which are both 
deproteinized xenografts used as bone grafts.
Material and Methods
Materials
The two commercial biomaterials used in this 
study derived from inorganic medullar bovine bone: 
1) Bio-Oss, consisting of granules (250 to 450 Pm) 
deproteinized at 300qC, according to the manu-
facturer’s data; 2) Gen-Ox, consisting of granules 
(with particles from 250 to 1,000 Pm) deproteinized 
at 950 – 1,000qC, according to the manufacturer’s 
data (Baumer S.A. – Brazil, Registration at the Min-
istry of Health No. 10345500001).
Physicochemical characterization
Morphological characterization of the materials 
was carried out through scanning electron micros-
copy (Zeiss, model DSM 940A, Oberkochen, Baden-
Württemberg, Germany) operating at 20 kV of elec-
trons acceleration. The presence of residues from the 
organic phase or different species of phosphate was 
assessed through the use of thermogravimetry and 
infrared spectroscopy, respectively. Thermogravim-
etry was performed from 50 to 950qC with a heat-
ing rate of 10qC/minute in a dynamic atmosphere of 
nitrogen (50 ml min-1) (TA Instruments, model TGA 
2950, coupled to a thermal analyzer of TA Instru-
ments, Model TA 2000), while Fourier-transformed 
infrared spectroscopy (FTIR) was obtained in a Per-
kin-Elmer (model 1000, Waltham, Massachusetts, 
USA) equipment.
In order to identify the crystalline phases in the 
xenografts, an X-ray diffractometer (DRX-Mini-
flex, Rigaku, Tokyo, Japan) was operated at 30 kV, 
15 mA and radiation CuKD, and the data was col-
lected from 5-100q 2T. The crystallinity of the mate-
rials was determined from the DRX patterns accord-
ing to the methodology proposed by Landi17 (2000); 
whereas the rate of degradation was determined 
threefold using protocol ISO/FDIS 10993-14:2001 
(in buffer Tris-HCl, pH 7.3 for 120 hours).
Results
Figure 1 shows the morphology of the materials 
studied. Bio-Oss presents particles of regular dimen-
sions with canaliculus and ridge (Figure 1, A – D); 
the presence of micrometric fragments is also ob-
served. The pores are sized 20-200 Pm (Figure 1A). 
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Inorganic Gen-Ox (Figure 1, E – H) also looks po-
rous (Figure 1, E and F); when magnified (Figure 1, 
G and H), the coalescence of the grains taken place 
during the calcination of the material at high tem-
peratures can also be seen. 
In the Fourier Transform infrared spectroscopy 
(FTIR), bands can be identified in the wavelength 
ranges of 1,554-1,569, 1,400-1,420 and 850 cm-1
corresponding to the functional group CO3
-2 of HA 
for Bio-Oss (Graph 1A). The phosphate group ap-
pears in both materials, but Gen-Ox (Graph 1B) 
presents better-defined bands between 600 and 
1,100 cm-1. Bands around 3,571 cm-1 are also high-
lighted indicating the presence of the structural O-
H stretch, as well as bands in 1,172, 1,088, 1,025 
and 963 cm-1, indicating the presence of PO4
-3
groups.
Bio-Oss and Gen-Ox thermogravimetric analysis 
(Graph 1, C and D, respectively) showed the materi-
als’ loss of mass due to the increase in temperature. 
Bio-Oss’ loss of mass was about 2.6, 0.5 and 2.4% 
between 30qC to 420qC, 420qC to 635qC (tem-
perature range between loss 1 and 2) and 630qC
to 950qC, respectively. The residual mass at 950qC
was 94.3%. Gen-Ox presented loss of mass at about 
0.35% between the initial temperature and 384qC, 
increasing up to 0.6% from 665qC to 950qC, result-
ing in a residual mass of 99.4%.
In the patterns obtained for X-ray diffraction 
(Graph 1, E – F), the major peaks identified were re-
lated to synthetic HA that according to card data 
JCPDS 9-432 (JCPDS-ICDD1, 1992) are placed at 
2T = 32, 33 and 26q, with relative intensity of 100, 
60 and 40%, respectively. From X-ray diffraction 
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Figure 1 - Electronmicrographs of 
the studied Biomaterials. Bio-Oss 
(A-D). Particles with regular dimensions 
covered with nanoparticles, and showing 
different pore sizes (arrows). Inorganic 
Gen-Ox (E-H). Porous particles showing 
the fusion of hydroxyapatite crystals. 
Magnification: A (70 X), B-C (1,000 X), 
D (10,000 X), E (50 X), F (100 X), G
(10,000 X), H (20,000 X).
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patterns the crystallinity was determined17 for each 
material, resulting in 40% and 96% for Bio-Oss and 
Gen-Ox, respectively.
The degradation test in Tris-HCl (120 h, pH 7.3, 
37qC) indicated the loss of mass, the average of 
4.7% (r 1.61) for Bio-Oss; however, no alteration of 
Gen-Ox mass was detected after 120 hours of deg-
radation assay.
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Graph 1 - Physico-chemical characterization of the xenograft implants. Fourier Transform Infrared Spectroscopy (FTIR) indi-
cates hydroxyapatite characteristic bands for Bio-Oss (A) and Inorganic Gen-Ox (B). Thermogravimetric analyses carried out 
for Bio-Oss (C, initial mass: 11.01 mg) and Inorganic Gen-Ox (D, initial mass: 17.88 mg). X-Ray diffraction for Bio-Oss (E) and 
Inorganic Gen-Ox (F).
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Discussion
Both materials analyzed are classified as xenografts 
from inorganic bovine bone, and are indicated as bone 
defect filling materials18,19 due to their osteoconduc-
tive properties.5,7 The study about synthetic and natu-
ral apatites has shown that the material degradation 
rate affects the biological response to the material.20-22
Recent studies have shown that fast absorption of the 
biomaterial may jeopardize adequate repair.20 On the 
other hand, non-resorbable materials can make some 
clinical procedures like grafts unfeasible.23 Thus, the 
processing way used by the manufacturers of natural 
and synthetic apatites affects both the physicochemi-
cal properties and the degradation rate of these bio-
materials, possibly affecting bone repair.10,24
It was observed through scanning electron mi-
croscopy that both materials presented pores on 
their surfaces (Figure 1). The degree of microporos-
ity depends on the compaction method of the start-
ing powder and the temperature of synthetic materi-
als or the use of natural materials on which the pores 
were biologically designed. The presence of pores in 
the granules increases the surface area of the xeno-
graft material, favoring osteoconduction, enabling 
bone growth also in the pores.10 Porosity was simi-
lar in both materials, but the effect of increased tem-
perature of sintering over the coalescence of apatite 
crystals is clear for Gen-Ox (Figures 1G and 1H).
Infrared spectral analysis has shown that both 
Bio-Oss and inorganic Gen-Ox have typical HA 
bands.3,24,25 Bands resolution is better in Gen-Ox, sug-
gesting high crystallinity, and no bands related to oth-
er compounds are observed. Preliminary data about 
material crystallinity may be obtained through infra-
red spectrum, especially from the bands that are in the 
590-610 cm-1 and 1,000 cm-1 regions.3,16 Diffracto-
grams of the materials assessed confirm the presence 
of hydroxyapatite (according to ICDD data, 9-432); 
however, again, the bands have better resolution for 
Gen-Ox. Wide bands observed in the Bio-Oss diffrac-
togram may be related to the different characteristics 
of the material, like the presence of non-crystalline 
phases (like organic residues), nanometric dimensioned 
crystals or defective powder structure.15,24,25
The loss of mass (nearly fourfold higher than that 
of Gen-Ox) observed in the thermogravimetric assay 
suggests the presence of residual organic material in 
Bio-Oss graft (around 3%). As it is expected for calci-
nated apatites (treatment temperature above 900qC), 
Gen-Ox showed a loss of mass above 700qC only; 
however, this loss is virtually none, about 0.3% of 
the sample. No reflections related to other phases of 
calcium phosphates were detected. It was confirmed 
through Landi’s17 (2000) method that Gen-Ox pre-
sented higher crystallinity than Bio-Oss, which con-
firmed the results of infrared and morphology of the 
crystals through scanning electron microscopy. This 
result is coherent with the calcination process to 
which it was submitted, since crystallinity is directly 
proportional to the processing temperature of the 
biomaterial. According to the manufacturers’ data, 
Bio-Oss is processed in a lower temperature than 
Gen-Ox, 300 and 1,000qC, respectively. The effect 
of processing temperature is related to the elimina-
tion of carbonate content in the bone, which hap-
pens at temperatures above 400qC only.4,15
Data about materials crystallinity is important, as 
the bioabsorption rate shall be compatible with the re-
pairing process of the recipient tissue. Calcium phos-
phates solubility depends on the relation Ca/P and, for 
the same composition, it depends on the crystallinity 
degree; so less crystalline materials are more soluble.4
Therefore, the presence of second phases (usually more 
soluble than HA) may compensate or null this effect.15
In this case there was no composition effect of the HA, 
prevailing the effect of crystallinity in in vitro degra-
dation. Thus, the degradation test indicated the loss 
of mass, at an average of 4.7% (r 1.61) for Bio-Oss, 
while no alteration of mass was detected in Gen-Ox.
The results suggest that the content of non-crys-
talline phases, probably organic matter and carbon-
ate, identified through thermogravimetric, infrared 
and X-ray diffraction analyses, generates a biomate-
rial of lower crystallinity and, consequently, more 
prone to degradation. Thus, the processing tempera-
ture may be a way to change the physicochemical 
properties of the material, producing materials with 
different reabsorption levels.
Conclusions
Both commercial materials are hydroxyapatite 
compounds. Bio-Oss is less crystalline than Gen-Ox 
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and is, therefore, more prone to degradation.
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